Fibrinolysis Shutdown in Severe COVID-19: Highly Prevalent but not Independently Predictive of Thrombosis or Poorer Outcomes

New York, NY

Disclosure Information: Dr Barie received funding from AKPA America, La Jolla, Portola, Tetraphase, and several medical malpractice defense attorneys for consultation work. Dr Cushing received consulting fees from Instrumentation Laboratory and Octapharma, and is a member of the Haemonetics Scientific Advisory Council.